USD 39.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others References Nikoletopoulou, V., Markaki, M., Palikaras, K

What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients
doi: 10.1016/j.cell.2005.12.039
Read the full methodology of how we rate CDs
This disease causes physical, psychosocial and economic problems in society 5
Tirzepatide also produces significant insulin sensitivity improvements, outperforming semaglutide in head-to-head diabetes trials